A hormone was developed at the University of Arizona to promote melanin (pigment tissues) in the body. The content of melanin in body is increased or brought to resemble the natural a-MSH produced in the physical body. It was earlier called Melanotan but with every research and rectification of the product it is now called Melanotan 2.
Melanotan 2 is developed so that it is 1,000 times more powerful than the all-natural a-MSH in the physical body. Researchers planned to use this peptide to stop cancer malignancy by decreasing the system’s necessity for exposure to sun. The peptide damages the effects of the rays to get a tan on the body.
So the researchers thought this might be used by people who’s actual skin is reasonable or lower in natural melanin so that they can potentially guard themselves from sun damage/ sunburn and eventually cancer.
The first scientific test saw the researchers from the College of Medicine, Pharmacology Division, University of Arizona in Tucson, Arizona facilitating a test on three men. They released a statement in 1996 that Melanotan II was given to the men (only 5 low doses every other day by subcutaneous injection) and there was a tanning effect on their bodies. The other effects were a stretching and yawning and a mild nausea for some of them.
In 1998, another test was conducted on 10 men by the Department of Pharmacology, University of Arizona College of Medicine that dealt with psychogenic erectile dysfunction. After the test, the released statement of the researchers mentioned that Melanotan-II is confirmed to be potent initiator of erections in men with psychogenic erectile dysfunction. The dose 0.025 mg/kg injected in the men gave them erections and there were some manageable side effects.
In 2000, the test was conducted by the Segment of Urology of The University of Arizona College of Medicine, on 20 men who had psychogenic and natural erectile disorder and the clinical report confirmed that the Melanotan II is a potent initiator of penile erection in men with erectile dysfunction.